Our work related to preventive health

The Life Saving Drugs Program (LSDP) pays for specific essential medicines to treat patients with ultra-rare and life-threatening diseases.

Lifeline provides information and immediate phone support to people who are struggling, 24 hours a day, 7 days a week.

Lifting Clinical Trials and Registries Capacity – Clinical Trials Networks initiative has been consolidated into a part of the Clinical Trials Activity initiative under the MRFF 10-year Investment Plan.

This program provides funding to strategically important aged care providers facing financial viability concerns. From 1 November 2025, MAP will expand to include both residential and Support at Home providers to ensure continuity of care for care recipients. Applications are by invitation only.

Maternal Health and First 2000 Days/Women’s Health has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year Investment Plan.

This program helps Aboriginal and Torres Strait Islander people who have chronic conditions to access health care. It does this by covering some costs – like travel and accommodation – for health professionals who provide the outreach services.

The Medical Research Commercialisation initiative will provide $450 million over 10 years from 2024–25 to support innovative early-stage health and medical research in Australia. It will help researchers transform ideas into life-saving medicines, devices and treatments to help future patients.